| 英文别名 |
Alogliptin benzoate;2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile benzoate;2-[[6-[(3R)-3-aMino-1-piperidinyl]-3,4-dihydro-3-Methyl-2,4-dioxo-1(2H)-pyriMidinyl]Methyl]-Benzonitrile Monobenzoate;SYR 322;Nesina;2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile,benzoic acid;2-[6-[3(R)-Aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-ylmethyl]benzonitrile benzoate;alogliptin;Alogliptin (Benzoate);alogliptin monobenzoate;SYR32;Vipidia (TN);Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-, monobenzoate (9CI);ALOGLIPTIN BENZOATE [JAN];ALOGLIPTIN BENZOATE [JAN];Q27888443;Q27888443;Q27888443;Alogliptin Benzoate?;Alogliptin Benzoate?;Alogliptin Benzoate?;CHEMBL227529;CHEMBL227529;CHEMBL227529;2-((6-((3R)-3-AMINO-1-PIPERIDINYL)-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL)METHYL)BENZONITRILE MONOBENZOATE;2-((6-((3R)-3-AMINO-1-PIPERIDINYL)-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL)METHYL)BENZONITRILE MONOBENZOATE;2-((6-((3R)-3-AMINO-1-PIPERIDINYL)-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL)METHYL)BENZONITRILE MONOBENZOATE;SCHEMBL476231;SCHEMBL476231;SCHEMBL476231;ALOGLIPTIN BENZOATE [VANDF];ALOGLIPTIN BENZOATE [VANDF];ALOGLIPTIN BENZOATE [VANDF];CS-0761;CS-0761;CS-0761;Benzonitrile, 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-, monobenzoate;Benzonitrile, 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-, monobenzoate;Benzonitrile, 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-, monobenzoate;2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl)methyl)benzonitrile monobenzoate;2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl)methyl)benzonitrile monobenzoate;2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl)methyl)benzonitrile monobenzoate;CHEBI:72324;CHEBI:72324;CHEBI:72324;(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile benzoate;(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile benzoate;(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile benzoate;KAZANO COMPONENT ALOGLIPTIN BENZOATE;KAZANO COMPONENT ALOGLIPTIN BENZOATE;KAZANO COMPONENT ALOGLIPTIN BENZOATE;SYR-322;SYR-322;SYR-322;ALOGLIPTIN BENZOATE [ORANGE BOOK];ALOGLIPTIN BENZOATE [ORANGE BOOK];ALOGLIPTIN BENZOATE [ORANGE BOOK];AKOS015917686;AKOS015917686;AKOS015917686;Alogliptin (as benzoate);Alogliptin (as benzoate);Alogliptin (as benzoate);DTXSID20582095;DTXSID20582095;DTXSID20582095;UNII-EEN99869SC;UNII-EEN9... |